| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | — | +45.2% |
| Cost of Revenue | $420K | — | +147.1% |
| Gross Profit | $691K | — | +16.1% |
| R&D Expense | $105K | — | -72.2% |
| SG&A Expense | $5.4M | — | +29.4% |
| Operating Income | -$4.8M | — | -21.6% |
| Net Income | -$4.5M | — | -4265.1% |
| EPS (Basic) | -$0.09 | — | — |
| EPS (Diluted) | -$0.09 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.3M | +109.5% | +17.7% |
| Accounts Receivable | $2.0M | -28.6% | +201.7% |
| Inventory | $4.6M | -6.6% | -23.6% |
| Current Assets | $14.5M | +26.7% | +7.3% |
| Total Assets | $16.7M | +8.5% | -7.0% |
| Current Liabilities | $1.9M | +5.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.2M | — | +59.4% |
| Capital Expenditures | $5K | — | +150.0% |
| Investing Cash Flow | -$58K | — | +42.0% |
| Financing Cash Flow | $5.1M | — | -11.0% |
| Free Cash Flow | -$1.3M | — | +59.3% |
| -86.2% |
| Total Liabilities | $2.3M | -41.8% | -85.1% |
| Stockholders' Equity | $14.4M | +25.6% | +462.3% |